Evidence map›Paper›PMID 26052505›Full record

ReviewFrontiers in oncology2015

Clinical Impact of the Immunome in Lymphoid Malignancies: The Role of Myeloid-Derived Suppressor Cells.

Calogero Vetro, Alessandra Romano, Flavia Ancora, Francesco Coppolino, Maria V Brundo, Salvatore A Raccuia, Fabrizio Puglisi, Daniele Tibullo, Piera La Cava, Cesarina Giallongo and 1 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Frontiers in oncology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Monocytic Myeloid Derived Suppressor Cells in Hematological Malignancies.International journal of molecular sciences · 2019
    Review
  5. Review
  6. Myeloid-derived suppressor cells in B cell malignancies.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Calogero VetroDivision of Haematology, AOU "Policlinico - Vittorio Emanuele", University of Catania , Catania , Italy.
Alessandra RomanoDivision of Haematology, AOU "Policlinico - Vittorio Emanuele", University of Catania , Catania , Italy.
Flavia AncoraDivision of Haematology, AOU "Policlinico - Vittorio Emanuele", University of Catania , Catania , Italy.
Francesco CoppolinoDepartment of Radiology, University of Palermo , Palermo , Italy.
Maria V BrundoDepartment of Biological, Geological and Environmental Sciences, University of Catania , Catania , Italy.
Salvatore A RaccuiaDepartment of Biological, Geological and Environmental Sciences, University of Catania , Catania , Italy ; National Research Council Institute for Agricultural and Forest Systems in the Mediterranean, National Research Council , Catania , Italy.
Fabrizio PuglisiDivision of Haematology, AOU "Policlinico - Vittorio Emanuele", University of Catania , Catania , Italy.
Daniele TibulloDivision of Haematology, AOU "Policlinico - Vittorio Emanuele", University of Catania , Catania , Italy.
Piera La CavaDivision of Haematology, AOU "Policlinico - Vittorio Emanuele", University of Catania , Catania , Italy.
Cesarina GiallongoDivision of Haematology, AOU "Policlinico - Vittorio Emanuele", University of Catania , Catania , Italy.
Nunziatina L ParrinelloDivision of Haematology, AOU "Policlinico - Vittorio Emanuele", University of Catania , Catania , Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The better definition of the mutual sustainment between neoplastic cells and immune system has been translated from the bench to the bedside acquiring value as prognostic factor. Additionally, it represents a promising tool for improving therapeutic strategies. In this context, myeloid-derived suppressor cells (MDSCs) have gained a central role in tumor developing with consequent therapeutic implications. In this review, we will focus on the biological and clinical impact of the study of MDSCs in the settings of lymphoid malignancies.

Indexed as

lymphomaMDSCsmicroenvironmentprognostication

Identifiers

PMID26052505
PMCPMC4440379

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.